Circle8 Group (CIRC) vs Rapid Micro Biosystems (RPID)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Rapid Micro Biosystems (RPID) has outperformed Circle8 Group (CIRC) over the past year, losing 82.4% versus a loss of 94.4%. Over five years, RPID leads with a -94.4% price change compared with -99.9% for CIRC. Rapid Micro Biosystems is the larger company by market cap ($37.4 million vs $16.0 million), about 2.3 times the size.
Circle8 Group converts more of its revenue into profit, with a net margin of -13.6% versus -140.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CIRC | RPID |
|---|---|---|
| Share price | $0.1361 | $0.735 |
| Market cap | $15.99M | $37.37M |
| 1-day change | -12.25% | -0.04% |
| YTD return | -89.77% | -74.66% |
| 1-year return | -94.44% | -82.37% |
| 5-year return | -99.88% | -94.41% |
| EPS (TTM) | $-2.14 | $-1.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $435.88M | $33.59M |
| Revenue growth (YoY) | -1.52% | +19.74% |
| Net income (latest FY) | $-59.43M | $-47.12M |
| Gross margin | 10.55% | — |
| Operating margin | -11.52% | -141.10% |
| Net margin | -13.63% | -140.30% |
| 52-week high | $4.56 | $4.94 |
| 52-week low | $0.136 | $0.58 |
| Distance from 52-week high | -97.02% | -85.12% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +682.31% |
| Average volume | 1.13M | 577.05K |
| Shares outstanding | 117.49M | 46.34M |
| Employees | 300 | 171 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Rapid Micro Biosystems is about 2.3 times larger than Circle8 Group by market value ($37.37M vs $15.99M).
- RPID has outperformed CIRC by 12.1 percentage points over the past year.
- Circle8 Group is more profitable, keeping -13.6 cents of every revenue dollar as net income versus -140.3 cents for Rapid Micro Biosystems.
- Rapid Micro Biosystems grew revenue faster in its latest fiscal year (+19.74% vs -1.52%).
About Circle8 Group
CIRC stock →Circle8 Group, Inc. provides talent management services.
Industrials · Biotechnology: Laboratory Analytical Instruments · 300 employees
About Rapid Micro Biosystems
RPID stock →Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.
Industrials · Biotechnology: Laboratory Analytical Instruments · 171 employees
CIRC vs RPID FAQ
Which is bigger, Circle8 Group or Rapid Micro Biosystems?
Rapid Micro Biosystems (RPID) is larger, with a market capitalization of $37.37M compared with $15.99M for Circle8 Group (CIRC).
Which stock has performed better over the past year, CIRC or RPID?
RPID returned -82.37% over the past 12 months, compared with -94.44% for CIRC (price return, excluding dividends). Past performance does not predict future results.
Are Circle8 Group and Rapid Micro Biosystems in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.